Global Blood Therapeutics Inc - Company Profile
Powered by 
All the data and insights you need on Global Blood Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Global Blood Therapeutics Inc Strategy Report
- Understand Global Blood Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Global Blood Therapeutics Clinical Trials
Determine Global Blood Therapeutics Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Global Blood Therapeutics Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| A Randomized, Double-blind, Placebo-controlled, Multicenter Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants with Sickle Cell Disease and Recurrent Vaso-occlusive Crises | GDCT0464313 | inclacumab | Hematological Disorders | Sickle Cell Disease; Sickle Cell Disease With Vaso-Occlusive Crisis | Phase II | Planned | Global Blood Therapeutics Inc |
| A Clinical Study to Investigate the Effect of Voxelotor on the QT Interval/Qt Interval Corrected for HeartRate (Qtc) and Also Evaluate the Relationship of Plasma Voxelotor Concentration And Electrophysiologic Effects in Healthy Subjects | GDCT0453136 | voxelotor | Hematological Disorders | Sickle Cell Disease; Sickle Cell Disease With Vaso-Occlusive Crisis | Phase I | Completed | Global Blood Therapeutics Inc |
| A Relative Bioavailability Study of Single Dose of 900 mg Tablet or 3×300 mg Tablet in Whole Blood | GDCT0453021 | voxelotor | Hematological Disorders | Sickle Cell Disease; Sickle Cell Disease With Vaso-Occlusive Crisis | Phase I | Completed | Global Blood Therapeutics Inc |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer